Thermo Fisher Scientific Inc. TMO recently closed the acquisition of a drug substance manufacturing site of GlaxoSmithKline plc GSK in Cork, Ireland much ahead of schedule. Valued at 90 million euros, ...
Ajinomoto Bio-Pharma Services is taking full control of an API manufacturing facility in India as the CDMO continues to bulk up in a market that favors companies that can do it all. Ajinomoto ...
C2 Pharma, which concentrates on hard-to-make ingredients, has picked up a new supply of digoxin. The deal will give it two supplies of API for making the sometimes-difficult-to-get drug. The ...
ANKLESHWAR, India--(BUSINESS WIRE)--RUSAN PHARMA PRIVATE LIMITED, a pharmaceutical company based in India specializing in the area of addiction treatment and pain management, recently announced that ...
Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active pharmaceutical ingredients (APIs) and critical GMP intermediates announced the ...
Enveda has been using AI to power its drug discovery platform for several years. The company injected $230 million into ...
CPHI Pharma Awards 2025 recognized innovations in bio/pharmaceutical development, emphasizing sustainability, drug delivery, and supply chain resilience. Notable winners included Corden Pharma for ...
BIOGGIO, Switzerland--(BUSINESS WIRE)--KD Pharma Group SA announced that it has acquired a manufacturing site in Seal Sands, United Kingdom. The KD Pharma UK LTD entity will expand KD Pharma’s ...
APIs are a key ingredient for making different kinds of medicines in the country. And yet, nearly 65-70% of supplies of APIs in the country are still imported from China. The government has encouraged ...
The world’s number two producer of active pharmaceutical ingredients (APIs) is for sale. Given the constant global demand for essential medicines, the business might seem like a lucrative asset. But ...
Pharmaceuticals are developed, designed, and commonly manufactured in laboratory settings. Laboratory testing is an essential need in almost every stage of pharmaceutical production and R&D, from the ...
The Indian Active Pharmaceutical Ingredients (API) market in 2025 was valued at US$14.2 billion and is expected to grow at a CAGR of 8.5% to reach US$21.46 billion by 2030. In contrast, the global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback